Artemis Medicare Services Limited

Informe acción NSEI:ARTEMISMED

Capitalización de mercado: ₹42.9b

Artemis Medicare Services Dirección

Dirección controles de criterios 2/4

El CEO de Artemis Medicare Services es Devlina Chakravarty , nombrado en Jan 2014, tiene una permanencia de 10.83 años. compensación anual total es ₹183.34M, compuesta por 35.3% salario y 64.7% primas, incluidas acciones y opciones de la empresa. posee directamente un 2.57% de las acciones de la empresa, por valor de ₹1.10B. La antigüedad media del equipo directivo y de la junta directiva es de 4.4 años y 7 años, respectivamente.

Información clave

Devlina Chakravarty

Chief Executive Officer (CEO)

₹183.3m

Compensación total

Porcentaje del salario del CEO35.3%
Permanencia del CEO10.8yrs
Participación del CEO2.6%
Permanencia media de la dirección4.4yrs
Promedio de permanencia en la Junta Directiva7yrs

Actualizaciones recientes de la dirección

We Think Shareholders Are Less Likely To Approve A Large Pay Rise For Artemis Medicare Services Limited's (NSE:ARTEMISMED) CEO For Now

Jul 18
We Think Shareholders Are Less Likely To Approve A Large Pay Rise For Artemis Medicare Services Limited's (NSE:ARTEMISMED) CEO For Now

Recent updates

Artemis Medicare Services Limited Recorded A 5.3% Miss On Revenue: Analysts Are Revisiting Their Models

Nov 18
Artemis Medicare Services Limited Recorded A 5.3% Miss On Revenue: Analysts Are Revisiting Their Models

We Think Shareholders Are Less Likely To Approve A Large Pay Rise For Artemis Medicare Services Limited's (NSE:ARTEMISMED) CEO For Now

Jul 18
We Think Shareholders Are Less Likely To Approve A Large Pay Rise For Artemis Medicare Services Limited's (NSE:ARTEMISMED) CEO For Now

Artemis Medicare Services Limited's (NSE:ARTEMISMED) P/E Is Still On The Mark Following 31% Share Price Bounce

Jul 16
Artemis Medicare Services Limited's (NSE:ARTEMISMED) P/E Is Still On The Mark Following 31% Share Price Bounce

After Leaping 27% Artemis Medicare Services Limited (NSE:ARTEMISMED) Shares Are Not Flying Under The Radar

Apr 13
After Leaping 27% Artemis Medicare Services Limited (NSE:ARTEMISMED) Shares Are Not Flying Under The Radar

Artemis Medicare Services (NSE:ARTEMISMED) Has A Pretty Healthy Balance Sheet

Jun 14
Artemis Medicare Services (NSE:ARTEMISMED) Has A Pretty Healthy Balance Sheet

Artemis Medicare Services (NSE:ARTEMISMED) Has A Somewhat Strained Balance Sheet

Mar 15
Artemis Medicare Services (NSE:ARTEMISMED) Has A Somewhat Strained Balance Sheet

Capital Allocation Trends At Artemis Medicare Services (NSE:ARTEMISMED) Aren't Ideal

Aug 31
Capital Allocation Trends At Artemis Medicare Services (NSE:ARTEMISMED) Aren't Ideal

Is Artemis Medicare Services (NSE:ARTEMISMED) A Risky Investment?

Jul 30
Is Artemis Medicare Services (NSE:ARTEMISMED) A Risky Investment?

Artemis Medicare Services (NSE:ARTEMISMED) Is Reinvesting At Lower Rates Of Return

May 13
Artemis Medicare Services (NSE:ARTEMISMED) Is Reinvesting At Lower Rates Of Return

Returns On Capital At Artemis Medicare Services (NSE:ARTEMISMED) Paint A Concerning Picture

Jan 11
Returns On Capital At Artemis Medicare Services (NSE:ARTEMISMED) Paint A Concerning Picture

Artemis Medicare Services (NSE:ARTEMISMED) Has A Pretty Healthy Balance Sheet

Dec 10
Artemis Medicare Services (NSE:ARTEMISMED) Has A Pretty Healthy Balance Sheet

There Are Reasons To Feel Uneasy About Artemis Medicare Services' (NSE:ARTEMISMED) Returns On Capital

Sep 11
There Are Reasons To Feel Uneasy About Artemis Medicare Services' (NSE:ARTEMISMED) Returns On Capital

Artemis Medicare Services (NSE:ARTEMISMED) Has A Somewhat Strained Balance Sheet

Jul 01
Artemis Medicare Services (NSE:ARTEMISMED) Has A Somewhat Strained Balance Sheet

There Are Reasons To Feel Uneasy About Artemis Medicare Services' (NSE:ARTEMISMED) Returns On Capital

May 11
There Are Reasons To Feel Uneasy About Artemis Medicare Services' (NSE:ARTEMISMED) Returns On Capital

We Think Artemis Medicare Services (NSE:ARTEMISMED) Is Taking Some Risk With Its Debt

Mar 16
We Think Artemis Medicare Services (NSE:ARTEMISMED) Is Taking Some Risk With Its Debt

Is Artemis Medicare Services (NSE:ARTEMISMED) Likely To Turn Things Around?

Jan 22
Is Artemis Medicare Services (NSE:ARTEMISMED) Likely To Turn Things Around?

Is Artemis Medicare Services (NSE:ARTEMISMED) A Risky Investment?

Nov 13
Is Artemis Medicare Services (NSE:ARTEMISMED) A Risky Investment?

Market Still Lacking Some Conviction On Artemis Medicare Services Limited (NSE:ARTEMISMED)

Jul 20
Market Still Lacking Some Conviction On Artemis Medicare Services Limited (NSE:ARTEMISMED)

Análisis de compensación del CEO

¿Cómo ha cambiado la remuneración de Devlina Chakravarty en comparación con los beneficios de Artemis Medicare Services?
FechaCompensación totalSalarioIngresos de la empresa
Sep 30 2024n/an/a

₹647m

Jun 30 2024n/an/a

₹560m

Mar 31 2024₹183m₹65m

₹491m

Dec 31 2023n/an/a

₹456m

Sep 30 2023n/an/a

₹445m

Jun 30 2023n/an/a

₹400m

Mar 31 2023₹139m₹46m

₹386m

Dec 31 2022n/an/a

₹412m

Sep 30 2022n/an/a

₹373m

Jun 30 2022n/an/a

₹363m

Mar 31 2022₹49m₹46m

₹318m

Dec 31 2021n/an/a

₹313m

Sep 30 2021n/an/a

₹301m

Jun 30 2021n/an/a

₹221m

Mar 31 2021₹51m₹48m

₹65m

Dec 31 2020n/an/a

-₹19m

Sep 30 2020n/an/a

-₹16m

Jun 30 2020n/an/a

₹38m

Mar 31 2020₹52m₹48m

₹198m

Compensación vs. Mercado: La compensación total de Devlina($USD2.17M) está por encima de la media de empresas de tamaño similar en el mercado Indian ($USD272.27K).

Compensación vs. Ingresos: La compensación de Devlina ha aumentado más de un 20% en el último año.


CEO

Devlina Chakravarty (56 yo)

10.8yrs

Permanencia

₹183,337,000

Compensación

Dr. Devlina Chakravarty, M.D., DNB, DMRD, Radiolog,y serves as Chief Executive Officer at Artemis Medicare Services Limited and its Managing Director and Executive Director since February 2, 2015. Dr. Chak...


Equipo directivo

NombrePosiciónPermanenciaCompensaciónPropiedad
Devlina Chakravarty
CEO, MD & Executive Director10.8yrs₹183.34m2.57%
₹ 1.1b
Sanjiv Kothari
Chief Financial Officerno data₹8.63msin datos
Poonam Makkar
Company Secretary & Compliance Officer2yrs₹4.24msin datos
Ashutosh Kumar Jha
Chief-Strategyno datasin datossin datos
Vivek Singh
Head of Legalno datasin datossin datos
Saras Malik
Chief People Officer of Human Resources & Trainingno datasin datossin datos
Manju Aggarwal
Chief Medical Services & Chairperson of Nephrology4.4yrssin datossin datos

4.4yrs

Permanencia media

Equipo directivo experimentado: El equipo directivo de ARTEMISMED se considera experimentado (4.4 años antigüedad media).


Miembros de la Junta

NombrePosiciónPermanenciaCompensaciónPropiedad
Devlina Chakravarty
CEO, MD & Executive Director9.6yrs₹183.34m2.57%
₹ 1.1b
Onkar Kanwar
Non-Executive Non-Independent Chairman18.2yrs₹400.00k0.0036%
₹ 1.6m
Neeraj Kanwar
Non-Executive & Non-Independent Director16.8yrs₹480.00ksin datos
Pallavi Shroff
Independent Directorless than a yearsin datossin datos
Nirmal Ganguly
Non-Executive & Non-Independent Director10.8yrs₹2.92msin datos
Akshay Kumar Chudasama
Independent Directorless than a year₹180.00ksin datos
Deepa Wadhwa
Non-Executive Independent Woman Director4.5yrs₹540.00ksin datos
Sunil Tandon
Non-Executive Independent Director3.5yrs₹520.00ksin datos
Sanjib Sen
Independent Director4.3yrs₹460.00ksin datos
Shalini Chand
Non-Executive & Non-Independent Director17.8yrs₹480.00ksin datos

7.0yrs

Permanencia media

62.5yo

Promedio de edad

Junta con experiencia: La junta directiva de ARTEMISMED se considera experimentada (7 años de antigüedad promedio).